Darwin Advisors, LLC Pfizer Inc Transaction History

Darwin Advisors, LLC

  • $356 Million
  • Q3 2024

A detailed history of Darwin Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Darwin Advisors, LLC holds 3,118 shares of PFE stock, worth $82,190. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,118
Holding current value
$82,190
% of portfolio
0.03%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024
BUY
$27.7 - $31.39 $86,368 - $97,874
3,118 New
3,118 $90,000
Q1 2023

Apr 18, 2023
SELL
$39.39 - $51.28 $20,364 - $26,511
-517 Reduced 9.08%
5,179 $211,000
Q4 2022

Jan 17, 2023
SELL
$41.75 - $54.5 $7,181 - $9,374
-172 Reduced 2.93%
5,696 $0
Q3 2022

Oct 18, 2022
SELL
$43.76 - $53.42 $23,236 - $28,366
-531 Reduced 8.3%
5,868 $256,000
Q2 2022

Aug 03, 2022
BUY
$46.53 - $55.17 $5,583 - $6,620
120 Added 1.91%
6,399 $318,000
Q1 2022

May 04, 2022
SELL
$45.75 - $56.69 $10,568 - $13,095
-231 Reduced 3.55%
6,279 $325,000
Q4 2021

Jan 21, 2022
SELL
$41.32 - $61.25 $11,610 - $17,211
-281 Reduced 4.14%
6,510 $352,000
Q3 2021

Oct 27, 2021
SELL
$39.25 - $50.42 $184,789 - $237,377
-4,708 Reduced 40.94%
6,791 $292,000
Q2 2021

Aug 12, 2021
BUY
$35.91 - $40.68 $10,880 - $12,326
303 Added 2.71%
11,499 $450,000
Q1 2021

May 17, 2021
SELL
$33.49 - $37.77 $11,855 - $13,370
-354 Reduced 3.06%
11,196 $405,000
Q4 2020

Feb 16, 2021
BUY
$33.47 - $42.56 $22,090 - $28,089
660 Added 6.06%
11,550 $425,000
Q3 2020

Oct 16, 2020
SELL
$31.75 - $37.25 $114,935 - $134,845
-3,620 Reduced 24.95%
10,890 $399,000
Q2 2020

Aug 06, 2020
SELL
$30.12 - $36.54 $166,955 - $202,541
-5,543 Reduced 27.64%
14,510 $474,000
Q1 2020

May 01, 2020
SELL
$27.03 - $38.62 $1.09 Million - $1.56 Million
-40,469 Reduced 66.87%
20,053 $654,000
Q4 2019

Feb 14, 2020
BUY
$32.92 - $37.36 $84,011 - $95,342
2,552 Added 4.4%
60,522 $2.37 Million
Q3 2019

Oct 16, 2019
BUY
$32.49 - $42.13 $63,712 - $82,616
1,961 Added 3.5%
57,970 $2.08 Million
Q2 2019

Aug 07, 2019
BUY
$36.98 - $41.52 $34,946 - $39,236
945 Added 1.72%
56,009 $2.43 Million
Q1 2019

May 01, 2019
BUY
$37.5 - $41.2 $67,462 - $74,118
1,799 Added 3.38%
55,064 $2.34 Million
Q4 2018

Jan 25, 2019
BUY
$38.47 - $43.86 $22,351 - $25,482
581 Added 1.1%
53,265 $2.32 Million
Q3 2018

Oct 23, 2018
BUY
$34.47 - $41.81 $255,181 - $309,519
7,403 Added 16.35%
52,684 $2.32 Million
Q2 2018

Aug 16, 2018
BUY
$32.98 - $35.16 $269,281 - $287,081
8,165 Added 22.0%
45,281 $1.65 Million
Q1 2018

May 08, 2018
BUY
$31.91 - $37.02 $129,299 - $150,005
4,052 Added 12.26%
37,116 $1.32 Million
Q4 2017

Feb 13, 2018
BUY
$33.26 - $35.29 $220,048 - $233,478
6,616 Added 25.02%
33,064 $1.2 Million
Q3 2017

Nov 09, 2017
BUY
$31.0 - $34.15 $819,888 - $903,199
26,448
26,448 $944,000

Others Institutions Holding PFE

# of Institutions
3,260
Shares Held
3.61B
Call Options Held
77.2M
Put Options Held
122M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Darwin Advisors, LLC Portfolio

Follow Darwin Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Darwin Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Darwin Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email